Literature DB >> 810603

Mason-Pfizer monkey virus: analysis and localization of virion proteins and glycoproteins.

G Schochetman, K Kortright, J Schlom.   

Abstract

The polypeptide composition of Mason-Pfizer monkey virus was determined using sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Six major polypeptides of molecular weights 68,000, 27,000, 20,000, 14,000, 12,000, and 10,000 were resolved regardless of the cell type (i.e., two human and two rhesus) in which the virus was grown. Protein gp68 (68,000) represented the major virus glycoprotein and protein gp20 (20,000) represented a minor glycoprotein of the virion, again regardless of the cell type of origin of the virus. Protein gp68 appears to be located on the outer surface of the viral envelope, as demonstrated by lactoperoxidase catalyzed iodination of intact virions. Additional glycoproteins were shown to be virion associated; their presence depended, however, on the cell type in which the virus was propagated.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 810603      PMCID: PMC355720          DOI: 10.1128/JVI.16.5.1208-1219.1975

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  A study of the relationship of reticuloendotheliosis virus to the avian leukosis-sarcoma complex of viruses.

Authors:  M S Halpern; E Wade; E Rucker; K L Baxter-Gabbard; A S Levine; R R Friis
Journal:  Virology       Date:  1973-06       Impact factor: 3.616

Review 2.  Biochemical properties of oncornavirus polypeptides.

Authors:  D P Bolognesi; G Huper; R W Green; T Graf
Journal:  Biochim Biophys Acta       Date:  1974-12-31

3.  A proposed nomenclature for the virion proteins of oncogenic RNA viruses.

Authors:  J T August; D P Bolognesi; E Fleissner; R V Gilden; R C Nowinski
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

4.  A new virus in a spontaneous mammary tumor of a rhesus monkey.

Authors:  H C Chopra; M M Mason
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

5.  Morphological and biophysical properties of the Mason-Pfizer monkey virus.

Authors:  J S Manning; A J Hackett
Journal:  J Natl Cancer Inst       Date:  1972-02       Impact factor: 13.506

6.  The metabolism of glucosamine by tissue culture cells.

Authors:  S Kornfeld; V Ginsburg
Journal:  Exp Cell Res       Date:  1966-03       Impact factor: 3.905

7.  Immunological properties of two polypeptides of Mason-Pfizer monkey virus.

Authors:  S R Tronick; J R Stephenson; S A Aaronson
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

8.  Evidence for crossing-over between avian tumor viruses based on analysis of viral RNAs.

Authors:  K Beemon; P Duesberg; P Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

9.  Purification, characterization, and comparison of the DNA polymerases from two primate RNA tumor viruses.

Authors:  J W Abrell; R C Gallo
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

10.  Characterization and separation of viral DNA polymerase in mouse milk.

Authors:  R S Howk; L A Rye; L A Killeen; E M Scolnick; W P Parks
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

View more
  14 in total

1.  Sialylatin of glycoproteins of murine mammary tumor virus, murine leukemia virus, and Mason-Pfizer monkey virus.

Authors:  R H Schloemer; J Schlom; G Schochetman; P Kimball; R R Wagner
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

2.  Interspecies radioimmunoassay for the major structural proteins of primate type-D retroviruses.

Authors:  D Colcher; Y A Teramoto; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

3.  Structural proteins of equine infectious anemia virus.

Authors:  W P Cheevers; C M Ackley; T B Crawford
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

4.  Molecular diversity among five different endogenous primate retroviruses.

Authors:  M L Bryant; C J Sherr; A Sen; G J Todaro
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

5.  Further evidence from tryptic peptide analysis for heterogeneity among type D retroviruses.

Authors:  W Uckert; I Hertling; J Denner
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

6.  Comparative large-scale propagation of retroviruses from Old World (Mason-Pfizer monkey virus) and New World (squirrel monkey virus) primates.

Authors:  C V Benton; H M Hodge; D L Fine
Journal:  In Vitro       Date:  1978-02

7.  Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus.

Authors:  S L Hu; J M Zarling; J Chinn; B M Travis; P A Moran; J Sias; L Kuller; W R Morton; G Heidecker; R E Benveniste
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  Mason-Pfizer like virus in kidney grafted patients.

Authors:  L Thiry; S Sprecher-Goldberger; P Vandenbussche; M Bossens; P Vereerstraten; O Hestermans-Medard
Journal:  Med Microbiol Immunol       Date:  1979-01-24       Impact factor: 3.402

9.  Type D retroviruses from human cells do not contain a minor glycoprotein shared by old world monkey type D viruses.

Authors:  V Wunderlich; W Uckert
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

10.  In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein.

Authors:  A Abe; S T Chen; A Miyanohara; T Friedmann
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.